Journals / Experimed / 2026 / Volume: 12 Issue: Supplement 1 Special Issue

SPEECH SUMMARY

Journal
Experimed
Pages
—
Publication Date
2022-04-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

.Omics Technologies in Life Sciences: From Genome to Therapy Yaşam Bilimlerinde Omik Teknolojileri: Genomdan Tedaviye

📌 3 Key Takeaways

🎯
Objective & Hypothesis:.Omics Technologies in Life Sciences: From Genome to Therapy Yaşam Bilimlerinde Omik Teknolojileri: Genomdan Tedaviye
📊
Key Findings & Data:.Omics Technologies in Life Sciences: From Genome to Therapy Yaşam Bilimlerinde Omik Teknolojileri: Genomdan Tedaviye
💡
Conclusion & Impact:.Omics Technologies in Life Sciences: From Genome to Therapy Yaşam Bilimlerinde Omik Teknolojileri: Genomdan Tedaviye
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:SPEECH SUMMARY · KONUŞMA ÖZETLERİ · AZIZ SANCAR INSTITUTE OF EXPERIMENTAL MEDICINE DAYS

Abstract

.Omics Technologies in Life Sciences: From Genome to Therapy Yaşam Bilimlerinde Omik Teknolojileri: Genomdan Tedaviye

🔖

Cite This Article

Çakmakoğlu, B. (2022). SPEECH SUMMARY. Experimed, Volume: 12 Issue: Supplement 1 Special Issue. https://ajindex.com/articles/1116614

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Iacobucci I, Wen J, Meggendorfer M, Choi JK, Shi L, Pounds SB, et al. Genomic subtyping and therapeutic targeting of acute erythroleukemia. Nat Genet. 2019 Apr; 51(4): 694-704. doi: 10.1038/s41588-019-0375-1
  2. Iacobucci I, Qu C, Varotto E, Janke LJ, Yang X, Seth A, et al. Modeling and targeting of erythroleukemia by hematopoietic genome editing. Blood. 2021 Mar 25; 137(12): 1628-1640. doi: 10.1182/blood.2020009103.